Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC)
dc.contributor.author | da Guarda, Caroline Conceic¸ão | |
dc.contributor.author | Yahoue´de´hou, Sètondji Cocou Modeste Alexandre | |
dc.contributor.author | Santiago, Rayra Pereira | |
dc.date.accessioned | 2023-05-04T07:27:02Z | |
dc.date.available | 2023-05-04T07:27:02Z | |
dc.date.issued | 2020-01-29 | |
dc.description.abstract | Sickle cell disease (SCD) consists of a group of hemoglobinopathies in which individuals present highly variable clinical manifestations. Sickle cell anemia (SCA) is the most severe form, while SC hemoglobinopathy (HbSC) is thought to be milder. Thus, we investigated the clinical manifestations and laboratory parameters by comparing each SCD genotype. We designed a cross-sectional study including 126 SCA individuals and 55 HbSC individuals in steady-state. Hematological, biochemical and inflammatory characterization was performed as well as investigation of previous history of clinical events. SCA patients exhibited most prominent anemia, hemolysis, leukocytosis and inflammation, whereas HbSC patients had increased lipid determinations. The main cause of hospitalization was pain crises on both genotypes. Vaso-occlusive events and pain crises were associated with hematological, inflammatory and anemia biomarkers on both groups. Cluster analysis reveals hematologi cal, inflammatory, hemolytic, endothelial dysfunction and anemia biomarkers in HbSC dis ease as well as SCA. The results found herein corroborate with previous studies suggesting that SCA and HbSC, although may be similar from the genetic point of view, exhibit different clinical manifestations and laboratory alterations which are useful to monitor the clinical course of each genotype. | en_US |
dc.description.sponsorship | ACE: Neglected Tropical Diseases and Forensic Biotechnology | en_US |
dc.identifier.citation | da Guarda CC, Yahoue´de´hou SCMA, Santiago RP, Neres JSdS, Fernandes CFdL, Aleluia MM, et al. (2020) Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC). PLoS ONE 15(1): e0228399. https://doi.org/ 10.1371/journal.pone.0228399 | en_US |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | http://hdl.handle.net/123456789/1698 | |
dc.language.iso | en | en_US |
dc.publisher | PLoS ONE | en_US |
dc.relation.ispartofseries | PLoS ONE; | |
dc.subject | Joelma Santana dos Santos Neres | en_US |
dc.subject | Ahmadu Bello University | en_US |
dc.subject | ACENTDFB | en_US |
dc.subject | Sickle cell anemia | en_US |
dc.subject | hemolysis | en_US |
dc.subject | leukocytosis | en_US |
dc.title | Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC) | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Sickle cell disease_ A distinction of two most frequent genotypes (HbSS and HbSC).pdf
- Size:
- 1.27 MB
- Format:
- Adobe Portable Document Format
- Description:
- Main article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: